BOCA Biolistics Bulk Specimens
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Boca Biolistics for bulk specimens of the following: HBV, HCV, Syphilis, HSV-1, HSV-2, Rubella, Zika, CMV, and Malaria for HIV incidence assay development to study the interference of these coinfections in incidence estimation. Boca Biolistics is the only company that has all of the specimens available at the time of purchase. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within three (3) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at cjoseph1@cdc.gov by 2:00PM Eastern 27 August 2019.
Evelyn Mickle, Contract Specialist, Email emickle@cdc.gov
